General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

Vegamour ×

Vegamour is a premium, direct-to-consumer, clean hair wellness brand.

  • Sector: Consumer
  • Headquarters: Los Angeles, California
  • Date Invested: 03/29/2021
  • Visit Website

Justo ×

Jüsto is a leading vertically-integrated online grocery platform in Mexico.

  • Sector: Consumer
  • Headquarters: Mexico City, Mexico
  • Date Invested: 03/29/2021
  • Visit Website

Zoomin ×

Zoomin is a leading knowledge and content orchestration platform.

  • Sector: Technology
  • Headquarters: New York, New York
  • Date Invested: 03/12/2021
  • Visit Website

Biotheus ×

Biotheus is a clinical development stage company treating cancer and autoimmune diseases through next-generation therapeutics.

  • Sector: Life Sciences
  • Headquarters: Zhuhai, China
  • Date Invested: 03/12/2021
  • Visit Website

Coalition ×

Coalition is a leading provider of cyber and commercial insurance, combining comprehensive insurance and cybersecurity tools to help businesses manage and mitigate cyber risk.

  • Sector: Financial Services
  • Headquarters: San Francisco, CA
  • Date Invested: 02/23/2021
  • Visit Website

Equality Health ×

Equality Health is a leading provider of technology, services and support for value-based care, serving the Medicaid, Medicare and ACA Exchange populations.

  • Sector: Healthcare
  • Headquarters: Phoenix, Arizona
  • Date Invested: 02/17/2021
  • Visit Website

CareMetx ×

CareMetx is a leading technology-enabled hub services company dedicated to improving patient access to specialty medications.

  • Sector: Healthcare
  • Headquarters: Bethesda, Maryland
  • Date Invested: 02/16/2021
  • Visit Website

Centessa Pharmaceuticals ×

Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process, with a subsidiary portfolio supported by a centralized infrastructure, asset-centric R&D model and the Centessa management team.

  • Sector: Life Sciences
  • Headquarters: Cambridge, MA
  • Date Invested: 01/29/2021
  • Visit Website

KGBio ×

Kalbe Genexine Biologics (“KGBio”) is an Indonesia-based joint venture between Kalbe Farma and Genexine. KGBio focuses on the in-licensing, clinical development, and manufacturing of biological products, especially in the area of immuno-oncology.

  • Sector: Life Sciences
  • Headquarters: Jakarta, Indonesia
  • Date Invested: 01/26/2021
  • Visit Website

Evisort ×

Evisort is an intelligent contract management platform that leverages proprietary AI to help enterprises categorize, search, and act on business-driving documents.

  • Sector: Technology
  • Headquarters: San Mateo, California
  • Date Invested: 01/22/2021
  • Visit Website

SPINS ×

SPINS is a leading provider of data, analytics and technology for health and wellness-focused consumer packaged goods brands and retailers.

  • Sector: Technology
  • Headquarters: Chicago, IL
  • Date Invested: 01/20/2021
  • Visit Website

Albert ×

Albert is a financial services company that provides financial advice and automated savings guidance to consumers.

  • Sector: Financial Services
  • Headquarters: Los Angeles, California
  • Date Invested: 01/12/2021
  • Visit Website

Open Farm ×

Open Farm is a premium pet food brand that provides high-quality nutrition for pets and supports the ethical and sustainable sourcing of ingredients.

  • Sector: Consumer
  • Headquarters: Toronto, Canada
  • Date Invested: 12/31/2020
  • Visit Website

Bolt ×

Bolt is a leading provider of optimized checkout, payments and fraud technology to online retailers.

  • Sector: Financial Services
  • Headquarters: San Francisco, California
  • Date Invested: 12/21/2020
  • Visit Website

Gen II ×

Gen II is a leading independent U.S. private capital focused fund administrator.

  • Sector: Financial Services
  • Headquarters: New York, New York
  • Date Invested: 12/11/2020
  • Visit Website

Pharvaris ×

Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition.

  • Sector: Life Sciences
  • Headquarters: Zug, Switzerland
  • Date Invested: 11/5/2020
  • Visit Website